메뉴 건너뛰기




Volumn 62, Issue 5, 2009, Pages 510-519

Cystatin C Provides more information than other renal function parameters for stratifying risk in patients with acute coronary syndrome;La cistatina C aporta más información que otros parámetros de función renal en la estratificación del riesgo de los pacientes con síndrome coronario agudo

Author keywords

Acute coronary syndrome; C reactive protein; Cistatina C; Cystatin C; Heart failure; Insuficiencia cardiaca; Prote na C reactiva; S ndrome coronario agudo

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; CYSTATIN C; TROPONIN I; BIOLOGICAL MARKER;

EID: 68049123420     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/S0300-8932(09)71031-0     Document Type: Article
Times cited : (35)

References (32)
  • 1
  • 2
    • 0034845524 scopus 로고    scopus 로고
    • Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease
    • M.G. Shlipak, J.A. Simon, D. Grady, F. Lin, N.K. Wenger, and C.D. Furger Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease J Am Coll Cardiol 38 2001 705 711
    • (2001) J Am Coll Cardiol , vol.38 , pp. 705-711
    • Shlipak, M.G.1    Simon, J.A.2    Grady, D.3    Lin, F.4    Wenger, N.K.5    Furger, C.D.6
  • 3
    • 0016916438 scopus 로고
    • Prediction of cretinine clearance from serum creatinine
    • D.W. Cockcroft, and M.H. Gault Prediction of cretinine clearance from serum creatinine Nephron 16 1976 31 41
    • (1976) Nephron , vol.16 , pp. 31-41
    • Cockcroft, D.W.1    Gault, M.H.2
  • 4
    • 0033574249 scopus 로고    scopus 로고
    • A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation
    • A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, and D. Roth A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation Ann Intern Med 130 1999 461 470
    • (1999) Ann Intern Med , vol.130 , pp. 461-470
    • Levey, A.S.1    Bosch, J.P.2    Lewis, J.B.3    Greene, T.4    Rogers, N.5    Roth, D.6
  • 5
    • 33744958852 scopus 로고    scopus 로고
    • Assesing kidney function - Measured and estimated glomerular filtration rate
    • L.A. Stevens, J. Coresh, T. Greene, and A.S. Levey Assesing kidney function - measured and estimated glomerular filtration rate N Engl J Med 354 2006 2473 2483
    • (2006) N Engl J Med , vol.354 , pp. 2473-2483
    • Stevens, L.A.1    Coresh, J.2    Greene, T.3    Levey, A.S.4
  • 6
    • 33747127870 scopus 로고    scopus 로고
    • Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease
    • M.G. Shlipak, R. Katz, M.J. Sarnak, L.M. Fried, A.B. Newman, and C. Stehman-Breen Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease Ann Intern Med 145 2006 237 246
    • (2006) Ann Intern Med , vol.145 , pp. 237-246
    • Shlipak, M.G.1    Katz, R.2    Sarnak, M.J.3    Fried, L.M.4    Newman, A.B.5    Stehman-Breen, C.6
  • 7
    • 34047180065 scopus 로고    scopus 로고
    • Association of cystatin C and estimated GFR with inflammatory biomarkers: The Heart and Soul Study
    • DOI 10.1093/ndt/gfl744
    • D. Singh, M.A. Whooley, J.H. Ix, S. Ali, and M.G. Shlipak Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study Nephrol Dial Transplant 22 2007 1087 1092 (Pubitemid 46523422)
    • (2007) Nephrology Dialysis Transplantation , vol.22 , Issue.4 , pp. 1087-1092
    • Singh, D.1    Whooley, M.A.2    Ix, J.H.3    Ali, S.4    Shlipak, M.G.5
  • 8
    • 9644259120 scopus 로고    scopus 로고
    • Serum cystatin C advantageous compared with serum cretatinine in the detection of mild but no severe diabetic nephropathy
    • A.G. Christensson, A.O. Grubb, J.A. Nilsson, K. Norrgren, G. Sterner, and G. Sundkvist Serum cystatin C advantageous compared with serum cretatinine in the detection of mild but no severe diabetic nephropathy J Inter Med 256 2004 510 518
    • (2004) J Inter Med , vol.256 , pp. 510-518
    • Christensson, A.G.1    Grubb, A.O.2    Nilsson, J.A.3    Norrgren, K.4    Sterner, G.5    Sundkvist, G.6
  • 9
    • 18644370841 scopus 로고    scopus 로고
    • Cystatin C and the risk of death and cardiovascular events among elderly persons
    • M.G. Shlipak, M.J. Sarnak, R. Katz, L.F. Fried, S.L. Seliger, and A.B. Newman Cystatin C and the risk of death and cardiovascular events among elderly persons N Eng J Med 352 2005 2049 2060
    • (2005) N Eng J Med , vol.352 , pp. 2049-2060
    • Shlipak, M.G.1    Sarnak, M.J.2    Katz, R.3    Fried, L.F.4    Seliger, S.L.5    Newman, A.B.6
  • 11
    • 0242543984 scopus 로고    scopus 로고
    • Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality
    • M. Gibson, D. Pinto, S. Murphy, D.A. Morrow, H.-P. Hobbach, and S.D. Wiviott Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality J Am Coll Cardiol 42 2003 1535 1543
    • (2003) J Am Coll Cardiol , vol.42 , pp. 1535-1543
    • Gibson, M.1    Pinto, D.2    Murphy, S.3    Morrow, D.A.4    Hobbach, H.-P.5    Wiviott, S.D.6
  • 12
    • 33645557765 scopus 로고    scopus 로고
    • La insuficiencia renal es un predictor independiente de la mortalidad en pacientes hospitalizados por insuficiencia cardiaca y se asocia con un peor perfil de riesgo cardiovascular
    • L. Grigorian, A. Varela, M. Pedreira, I. Gómez, A. Virgós, and J.R. González-Juanatey La insuficiencia renal es un predictor independiente de la mortalidad en pacientes hospitalizados por insuficiencia cardiaca y se asocia con un peor perfil de riesgo cardiovascular Rev Esp Cardiol 59 2006 99 108
    • (2006) Rev Esp Cardiol , vol.59 , pp. 99-108
    • Grigorian, L.1    Varela, A.2    Pedreira, M.3    Gómez, I.4    Virgós, A.5    González-Juanatey, J.R.6
  • 13
    • 3442895699 scopus 로고    scopus 로고
    • Renal function and long term mortality after unstable angina/non-ST segment elevation myocardial infarction treated very early an d predominatly with percutaneous coronary intervention
    • C. Mueller, F.-J. Neumann, A. Perruchoud, and H.J. Buettner Renal function and long term mortality after unstable angina/non-ST segment elevation myocardial infarction treated very early an d predominatly with percutaneous coronary intervention Heart 90 2004 902 907
    • (2004) Heart , vol.90 , pp. 902-907
    • Mueller, C.1    Neumann, F.-J.2    Perruchoud, A.3    Buettner, H.J.4
  • 15
    • 1942506539 scopus 로고    scopus 로고
    • Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: A pooled analysis of community-based studies
    • D.E. Wiener, H. Tighiouart, and M.G. Amin Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies J Am Soc Nephrol 15 2004 1307 1315
    • (2004) J Am Soc Nephrol , vol.15 , pp. 1307-1315
    • Wiener, D.E.1    Tighiouart, H.2    Amin, M.G.3
  • 16
    • 34548654734 scopus 로고    scopus 로고
    • The relationship between renal function and cardiac structure, function, and prognosis after myocardial infarction: The VALIANT Echo Study
    • A. Verma, N.S. Anavekar, A. Meris, J.J. Thune, J.M. Arnold, and J.K. Ghali The relationship between renal function and cardiac structure, function, and prognosis after myocardial infarction: the VALIANT Echo Study J Am Coll Cardiol 50 2007 1238 1245
    • (2007) J Am Coll Cardiol , vol.50 , pp. 1238-1245
    • Verma, A.1    Anavekar, N.S.2    Meris, A.3    Thune, J.J.4    Arnold, J.M.5    Ghali, J.K.6
  • 17
    • 33749254268 scopus 로고    scopus 로고
    • Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction
    • P. Jose, H. Skali, N. Anavekar, C. Tomson, H.M. Krumholz, and J.L. Rouleau Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction J Am Soc Nephrol 17 2006 2886 2891
    • (2006) J Am Soc Nephrol , vol.17 , pp. 2886-2891
    • Jose, P.1    Skali, H.2    Anavekar, N.3    Tomson, C.4    Krumholz, H.M.5    Rouleau, J.L.6
  • 18
    • 0029906706 scopus 로고    scopus 로고
    • Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin e in high-risk patients with diabetes. the MICRO-HOPE Study. Microalbuminuria, cardiovascular, and renal outcomes. Heart Outcomes Prevention Evaluation
    • H.C. Gerstein, J. Bosch, J. Pogue, D.W. Taylor, B. Zinman, and S. Yusuf Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin E in high-risk patients with diabetes. The MICRO-HOPE Study. Microalbuminuria, cardiovascular, and renal outcomes. Heart Outcomes Prevention Evaluation Diabetes Care 9 1996 1225 1228
    • (1996) Diabetes Care , vol.9 , pp. 1225-1228
    • Gerstein, H.C.1    Bosch, J.2    Pogue, J.3    Taylor, D.W.4    Zinman, B.5    Yusuf, S.6
  • 19
    • 33746196582 scopus 로고    scopus 로고
    • Renal function and effectiveness of angiotensinconverting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial
    • S.D. Solomon, M.M. Rice, K. Jablonski, P. Jose, M. Domanski, and M. Sabatine Renal function and effectiveness of angiotensinconverting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial Circulation 114 2006 26 31
    • (2006) Circulation , vol.114 , pp. 26-31
    • Solomon, S.D.1    Rice, M.M.2    Jablonski, K.3    Jose, P.4    Domanski, M.5    Sabatine, M.6
  • 20
    • 20844451359 scopus 로고    scopus 로고
    • Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction
    • M.P. Tokmakova, H. Skali, S. Kenchaiah, E. Braunwald, J.L. Rouleau, and M. Packer Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction Circulation 110 2004 3667 3673
    • (2004) Circulation , vol.110 , pp. 3667-3673
    • Tokmakova, M.P.1    Skali, H.2    Kenchaiah, S.3    Braunwald, E.4    Rouleau, J.L.5    Packer, M.6
  • 21
    • 34347350171 scopus 로고    scopus 로고
    • Chronic kidney disease effects on the cardiovascular system
    • W. Schiffrin, M.L. Lipman, and J.F. Mann Chronic kidney disease effects on the cardiovascular system Circulation 116 2007 85 97
    • (2007) Circulation , vol.116 , pp. 85-97
    • Schiffrin, W.1    Lipman, M.L.2    Mann, J.F.3
  • 22
    • 36148979642 scopus 로고    scopus 로고
    • The cardioprotective effects of the angiotensin-converting enzyme inhibitor perindopril in patients with stable coronary artery disease are not modified by mild to moderate renal insufficiency: Insights from the EUROPA trial
    • J.J. Brugts, E. Boersma, M. Chonchol, J.W. Deckers, M. Bertrand, and W.J. Remme The cardioprotective effects of the angiotensin-converting enzyme inhibitor perindopril in patients with stable coronary artery disease are not modified by mild to moderate renal insufficiency: insights from the EUROPA trial J Am Coll Cardiol 50 2007 2148 2155
    • (2007) J Am Coll Cardiol , vol.50 , pp. 2148-2155
    • Brugts, J.J.1    Boersma, E.2    Chonchol, M.3    Deckers, J.W.4    Bertrand, M.5    Remme, W.J.6
  • 23
    • 37148999674 scopus 로고    scopus 로고
    • Renal dysfunction, as measure by modification of diet in renal disease equations, and outcome with advance heart failure
    • R.S. Gardner, K.S. Chong, E. O'Meara, A. Jardine, I. Ford, and T.A. McDonagh Renal dysfunction, as measure by modification of diet in renal disease equations, and outcome with advance heart failure Eur Heart J 28 2007 3027 3033
    • (2007) Eur Heart J , vol.28 , pp. 3027-3033
    • Gardner, R.S.1    Chong, K.S.2    O'Meara, E.3    Jardine, A.4    Ford, I.5    McDonagh, T.A.6
  • 24
    • 33846194035 scopus 로고    scopus 로고
    • Association of Cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: Data from the Heart and Soul study
    • J.H. Ix, M.G. Shlipak, G.M. Chertow, and M.A. Whooley Association of Cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul study Circulation 115 2007 173 179
    • (2007) Circulation , vol.115 , pp. 173-179
    • Ix, J.H.1    Shlipak, M.G.2    Chertow, G.M.3    Whooley, M.A.4
  • 25
    • 12944289667 scopus 로고    scopus 로고
    • Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: More than simply a marker of glomerular filtration rate
    • DOI 10.1373/clinchem.2004.041889
    • W. Koenig, D. Twardella, H. Brenner, and D. Rothenbacher Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate Clin Chem 51 2005 321 327 (Pubitemid 40175801)
    • (2005) Clinical Chemistry , vol.51 , Issue.2 , pp. 321-327
    • Koenig, W.1    Twardella, D.2    Brenner, H.3    Rothenbacher, D.4
  • 26
    • 6444224408 scopus 로고    scopus 로고
    • Cystatin C: A novel predictor of outcome in suspected or confirmed non-ST- elevation acute coronary syndrome
    • T. Jernberg, B. Lindahl, S. James, A. Larsson, L.O. Hansson, and L. Wallentin Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST- elevation acute coronary syndrome Circulation 110 2004 2342 2348
    • (2004) Circulation , vol.110 , pp. 2342-2348
    • Jernberg, T.1    Lindahl, B.2    James, S.3    Larsson, A.4    Hansson, L.O.5    Wallentin, L.6
  • 28
    • 33745295944 scopus 로고    scopus 로고
    • Cinética de la proteína C reactiva en las distintas manifestaciones clínicas del síndrome coronario agudo
    • P.L. Sánchez, M.V. Rodríguez, E. Villacorta, C. Albarrán, I. Cruz, and J.M. Moreiras Cinética de la proteína C reactiva en las distintas manifestaciones clínicas del síndrome coronario agudo Rev Esp Cardiol 59 2006 441 447
    • (2006) Rev Esp Cardiol , vol.59 , pp. 441-447
    • Sánchez, P.L.1    Rodríguez, M.V.2    Villacorta, E.3    Albarrán, C.4    Cruz, I.5    Moreiras, J.M.6
  • 30
    • 21544476972 scopus 로고    scopus 로고
    • Genotype and plasma concentration of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events
    • M. Loew, M.M. Hoffmann, W. Koenig, H. Brenner, and D. Rothenbacher Genotype and plasma concentration of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events Arterioscler Thromb Vasc Biol 25 2005 1470 1474
    • (2005) Arterioscler Thromb Vasc Biol , vol.25 , pp. 1470-1474
    • Loew, M.1    Hoffmann, M.M.2    Koenig, W.3    Brenner, H.4    Rothenbacher, D.5
  • 31
    • 33644538537 scopus 로고    scopus 로고
    • Plasma cystatin-C and development or coronary heart disease: The PRIME study
    • G. Luc, J.M. Bard, C. Lesueur, D. Arveiler, A. Evans, and P. Amouyel Plasma cystatin-C and development or coronary heart disease: the PRIME study Atherosclerosis 185 2006 375 380
    • (2006) Atherosclerosis , vol.185 , pp. 375-380
    • Luc, G.1    Bard, J.M.2    Lesueur, C.3    Arveiler, D.4    Evans, A.5    Amouyel, P.6
  • 32
    • 15944399792 scopus 로고    scopus 로고
    • Cystatin C, serum creatinine and estimates of kidney function: Searching for better measures of kidney function and cardiovascular risk
    • A. Levin Cystatin C, serum creatinine and estimates of kidney function: searching for better measures of kidney function and cardiovascular risk Ann Intern Med 142 2005 586 588
    • (2005) Ann Intern Med , vol.142 , pp. 586-588
    • Levin, A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.